Pericoronary adipose tissue as storage and supply site for oxidized low-density lipoprotein in human coronary plaques

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Uchida, Yasumi ^a,b   Uchida, Yasuto ^c   Shimoyama, Ei ^d   Hiruta, Nobuyuki ^e   Kishimoto, Toshihiko ^e   Watanabe, Soichiro ^e  

^a The Japan Foundation   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tsukuba Memorial Hospital   (Japan)

^d Funabashi Futawa Hospital   (Japan)

^e TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; OXIDIZED LOW DENSITY LIPOPROTEIN; CD6 ANTIGEN; LEUKOCYTE ANTIGEN; LOW DENSITY LIPOPROTEIN; T LYMPHOCYTE ANTIGEN;

ACUTE HEART INFARCTION; ADIPOSE TISSUE; ADULT; ADVENTITIA; AGED; ARTERY INTIMA; ARTICLE; BLOOD VESSEL WALL; BRAIN INFARCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC NEPHROPATHY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MIDDLE AGED; PERICORONARY ADIPOSE TISSUE; PROTEIN LOCALIZATION; SUBARACHNOID HEMORRHAGE; SUDDEN DEATH; VASA VASORUM; ATHEROSCLEROTIC PLAQUE; AUTOPSY; CORONARY BLOOD VESSEL; INTIMA; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOPSY; CORONARY VESSELS; FEMALE; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; TUNICA INTIMA; VASA VASORUM;

EID: 84962071088     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150862     Document Type: Article

References (31)

1. Fuster V, Badimon L (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250 (1992). PMID: 1727977
2. Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Oie E et al (2008) Atherosclerotic plaque stability - what determines the fate of plaque? Prog Cardiovasc Dis. 51:183-194. doi: 10.1016/j.pcad. 2008.09.001 PMID: 19026853
3. Shah PK. (2009) Inflammation and plaque vulnerability. Cardiovasc Drugs Ther 23:31-40. doi: 10. 1007/s10557-008-6147-2 PMID: 18949542
4. Chen JH, Riazzy M, Smith EM, Proud CG, Steinbrecher UP, Duronio V (2009) Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler Thromb Vasc Biol 29:92-98. doi: 10.1161/ATVBAHA.108.174599 PMID: 18988891
5. Park YM, Febbraio M, Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. Clin Inves 119:136-145.
6. Matsuura E, Hughes GR, Khamashta MA (2008) Oxidation of LDL and its clinical implication. Autoimmun Rev 7:558-566. doi: 10.1016/j.autrev. 2008.04.018 PMID: 18625445
7. Li W, Yuan XM, Olsson AG, Brunk UT (1998) Uptake of oxidized LD by macrophages results in partial lysosomal enzyme inactivation and delocation. Arterioscler Thromb Vasc Biol 18:177-184. PMID: 9484981
8. Takahashi K, Takeya M, Sakashita N (2002) Multifunctional roles of macrophages in the development and progression of atherosclerosis in human and experimental animals. Med Electron Microsc 35:179-203. PMID: 12658354
9. Libby P (2015) The vascular biology of atherosclerosis. In: Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E (editors) Heart disease 10th Edition. Elsevier Saunders Ltd, Philadelphia 873-890.
10. Yoshida H, Kisugi R (2011) Mechanisms of LDL oxidation. Chimica Acta 411:1875-1882.
11. Romijin MA, Danad I, Bakkum MJ, Stuijfzand WJ, Tulevski II, Somsen GA, et al (2015) Incremental diagnostic value of epicardial adipose tissue for the detection of functionally relevant coronary artery disease. Atherosclerosis. 242:161-166. doi: 10.1016/j.atherosclerosis.2015.07.005 PMID: 26188540
12. Szasz T, Webb C (2012) Perivascular adipose tissue: more than just a structural support. Clinical Science 122:1-12. doi: 10.1042/CS20110151 PMID: 21910690
13. Uchida Y (2001) Angioscopes and its manipulation. In: Uchida Y, (editor) Coronary angioscopy. Futura Publishing LTD, Armonk, NY, 11-24.
14. Uchida Y (2001) Clinical classification of atherosclerotic coronary plaques. In: Uchida Y. (editor), Coronary angioscopy. Futura Publishing Ltd, Armonk, NY, 71-81.
15. Uchida Y, Maezawa Y, Uchida Y, Hiruta N, Shimoyama E, Kawai S (2013) Localization of oxidized lowdensity lipoprotein and its relation to plaque morphology in human coronary artery. PLosOne 8:e55188.
16. Yamada H, Sata M (2015) Role of pericardial fat. The good, the bad and the ugly. J Cardiol 2015;65:2-4. doi: 10.1016/j.jjcc.2014.07.004 PMID: 25149094
17. Boyd HC, Gown AM, Wolfbauer G, Chait A (1989) Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 135:815-825. PMID: 2683796
18. De Paoli F, Stales B, Chinetti-Gbaguidi G (2014) Macrophage phenotypes and their modulation in atherosclerosis. Circ J 78:1775-1781. PMID: 24998279
19. Holness CL, Simmons DL (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 15:1603-1613.
20. Tada Y, Ogawa M, Watanabe R, Zempo H, Takamura C, Suzuki J, et al (2014) Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditis. Expert Opin Invest Drugs. 23:149-162.
21. Donne D, Heusele C, Simon C, Pandaloni D (1985) 4', 6-diamidino-2-phenylindole, a fluoresce23:149-162nt probe for tubulin and microtubules. J Biol Chem 260:2891-2825.
22. Bourlier V, Zakaroff-Girard A, Milanville A, De Barros S, Maumus M, Sengenes C, et al (2008) Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 117:806-815. doi: 10.1161/CIRCULATIONAHA.107.724096 PMID: 18227385
23. Li J, Liu CH, Xu DL, Go B (2015) Clinicopathological significance of CD206-positive macrophages in pathents with acute tubulointerstitial disease. Int J Clin Exp Pathol. 8:11386-11392. PMID: 26617864
24. Verhagen SN, Visseren FL (2011) Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 214:3-10. doi: 10.1016/j.atherosclerosis.2010.05.034 PMID: 20646709
25. Toth PP, Davidson MH (2010) High-density lipoproteins: marker of cardiovascular risk and therapeutic target. J Clin Lipidol. 4:359-364. doi: 10.1016/j.jacl.2010.08.002 PMID: 21122679
26. Cho KH. Biomedical implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 2009;42:393-400. PMID: 19643035
27. Peng ZY, Zhao SP, He BM, Peng DQ, Hu M (2011) Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway. Mol Cell Biochem. 351:243-249. doi: 10.1007/s11010-011-0731-7 PMID: 21264497
28. Rader DJ (2006) Molecular regulation of HDL metabolism and function: Implications for novel therapies. J Clin Invest 116:3090-3100. PMID: 17143322
29. Uchida Y, Morita T, Nakamura F (1995) Observation of atherosclerotic lesions by an intravascular microscopy in patients with arteriosclerosis obliterance. Am Heart J 130:1114-1119. PMID: 7484744
30. Uchida Y, Uchida Y, Kawai S, Kanamaru R, Sugiyama Y, Tomaru T, et al (2010) Detection of vulnerable coronary plaques by color fluorescent angioscopy. JACC Cardiovasc Imaging 3:398-408. doi: 10. 1016/j.jcmg.2009.09.030 PMID: 20394902
31. Uchida Y (1995) Pericardioscopy. In: Uchida Y, editor. Atlas of Cardioangioscopy. Medical View Ltd, Tokyo 164-166.